BMRN vs GPN · P/E 40, rev $1.76B vs P/E 24, rev $6.29B
Biomarin Pharmaceutical Inc (BMRN) versus Global Payments Inc (GPN) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Global Payments Inc (GPN) is a specialty business services company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported GPN revenue for 2026-06-30 was $6.29B. Net income was -$1.79B. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. GPN currently screens at market cap $18.14B and trailing P/E 24.4.
Not investment advice. Open the BMRN and GPN stock pages for the full models.
Not investment advice.